GO Capital Fund - Venture Capital | BDC.ca
logo BDC

GO Capital

In light of the challenges faced by very early stage technology companies in Quebec in the mid-2000s, BDC Capital established GO Capital, a venture capital fund dedicated to creating and supporting seed and start-up companies operating in the life sciences and technology sectors.

While the new investment period for GO Capital closed in November 2011, it continues to provide support to its portfolio companies.

GO Capital’s limited partners are:

  • FIER Partenaires
  • Caisse de dépôt et placement du Québec
  • BDC Capital
  • Fonds de solidarité FTQ
  • Fondaction CSN

BDC Capital manages the partnership's investments, participates as a limited partner and matches GO Capital's investments.

Go Capital’s portfolio companies are: Alethia Biotherapeutics, LeddarTech, Milestone Pharmaceuticals, and Neuralitic Systems.

Certain news link to external sites and are presented in French only.